ArticlebioRxiv : the preprint server for biology2026
RAREsim2: Flexible simulation of rare variant genetic data using real haplotypes.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Summary: Realistic simulated data is critical for advancing methodological development and optimizing study design in genetics research. However, many genetic simulation tools are unable to replicate the distribution of rare variants or incorporate key genetic information, such as functional annotations and linkage disequilibrium. RAREsim, an accurate rare-variant simulation algorithm that uses real genetic haplotypes, was developed to address these limitations. Here, we introduce RAREsim2, an update that provides both streamlined software and new functionalities for simulating individual-level differences (e.g., cases vs controls, technological or batch effects) and variant-level differences to represent a variety of causal models.We demonstrate RAREsim2's utility with three rare variant association methods (Burden, SKAT, and SKAT-O) across several simulation scenarios: causal variants only in cases, causal variants in both cases and controls, and no causal variants. Type I Error was maintained and the optimal test matched previously known patterns: Burden performed best given a large amount of causal variants with the same direction of effect; SKAT performed best given causal variants with opposite directions of effect. SKAT-O was powerful across all simulation scenarios. We highlight RAREsim2's capabilities to simulate various genetic ancestries (African, East Asian, Non-Finnish European, and South Asian), gene sizes (~20-80 functional rare variants per gene), strengths of association (20%, 40%, 60% functional variants), and proportions of risk variants (1, 0.75, 0.5). Importantly, real genetic regions can be simulated to include known variant functions and disease associations. Ultimately, RAREsim2 offers additional flexibility and ease in simulating a multitude of realistic genetic scenarios. Availability and implementation: The RAREsim2 python package is available at https://github.com/Hendricks-Research-Team/RAREsim2 and the code for the example demonstration is available at https://github.com/JessMurphy/RAREsim2_demo . Contact: jessica.murphy@cuanschutz.edu.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.